Albrecht Stenzinger, MD
Albrecht Stenzinger, MD
Institute of Pathology, University Hospital Heidelberg, Germany
Bestätigte E-Mail-Adresse bei med.uni-heidelberg.de
Titel
Zitiert von
Zitiert von
Jahr
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ...
Nature biotechnology 31 (6), 539-544, 2013
7642013
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma …
A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ...
Journal of clinical oncology 30 (13), 1438-1446, 2012
4502012
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
TA Chan, M Yarchoan, E Jaffee, C Swanton, SA Quezada, A Stenzinger, ...
Annals of Oncology 30 (1), 44-56, 2019
2242019
Detection and segmentation of cell nuclei in virtual microscopy images: a minimum-model approach
S Wienert, D Heim, K Saeger, A Stenzinger, M Beil, P Hufnagl, M Dietel, ...
Scientific reports 2, 503, 2012
2092012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
F Sahm, D Capper, M Preusser, J Meyer, A Stenzinger, F Lasitschka, ...
Blood, The Journal of the American Society of Hematology 120 (12), e28-e34, 2012
1852012
KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology
W Weichert, C Schewe, A Lehmann, C Sers, C Denkert, J Budczies, ...
The Journal of Molecular Diagnostics 12 (1), 35-42, 2010
1182010
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
N Ertych, A Stolz, A Stenzinger, W Weichert, S Kaulfuß, P Burfeind, ...
Nature cell biology 16 (8), 779-791, 2014
1142014
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ...
Nature medicine 22 (3), 278, 2016
1062016
The landscape of metastatic progression patterns across major human cancers
J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ...
Oncotarget 6 (1), 570, 2015
1022015
Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with …
V Endris, R Penzel, A Warth, A Muckenhuber, P Schirmacher, ...
The Journal of molecular diagnostics 15 (6), 765-775, 2013
962013
mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours
A Kasajima, M Pavel, S Darb-Esfahani, A Noske, A Stenzinger, H Sasano, ...
Endocrine-related cancer 18 (1), 181, 2011
952011
The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)
T Hristozova, R Konschak, C Stromberger, A Fusi, Z Liu, W Weichert, ...
Annals of oncology 22 (8), 1878-1885, 2011
892011
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, ...
British journal of cancer 109 (10), 2665-2674, 2013
882013
ROS1 expression and translocations in non‐small‐cell lung cancer: clinicopathological analysis of 1478 cases
A Warth, T Muley, H Dienemann, B Goeppert, A Stenzinger, PA Schnabel, ...
Histopathology 65 (2), 187-194, 2014
872014
Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway
B Goeppert, C Konermann, CR Schmidt, O Bogatyrova, L Geiselhart, ...
Hepatology 59 (2), 544-554, 2014
832014
Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab–docetaxel treatment
I Tinhofer, K Klinghammer, W Weichert, M Knödler, A Stenzinger, T Gauler, ...
Clinical Cancer Research 17 (15), 5197-5204, 2011
822011
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype
A Warth, R Penzel, H Lindenmaier, R Brandt, A Stenzinger, E Herpel, ...
European Respiratory Journal 43 (3), 872-883, 2014
782014
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas
A Warth, A Stenzinger, AC von Brünneck, B Goeppert, J Cortis, I Petersen, ...
European respiratory journal 40 (5), 1221-1227, 2012
782012
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
A Warth, J Cortis, A Soltermann, M Meister, J Budczies, A Stenzinger, ...
British journal of cancer 111 (6), 1222-1229, 2014
752014
Correlation of radio-and histomorphological pattern of pulmonary adenocarcinoma
M Lederlin, M Puderbach, T Muley, PA Schnabel, A Stenzinger, ...
European respiratory journal 41 (4), 943-951, 2013
732013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20